VAERS Admits Fewer Than 1% of Vaccine Adverse Events Are Reported

By Martin Armstrong
Global Research, October 28, 2021
Armstrong Economics 26 October 2021
Region:
Theme: ,

 

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

Visit and follow us on Instagram at @crg_globalresearch.

***

 

The people behind the Vaccine Adverse Event Reporting System (VAERS) have admitted that “fewer than 1% of vaccine adverse events are reported” in an early grant:

“Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA). Likewise, fewer than 1% of vaccine adverse events are reported. Low reporting rates preclude or slow the identification of “problem” drugs and vaccines that endanger public health.”

VAERS published their later numbers, and perhaps we should consider this data representative of fewer than 1% of vaccinated individuals:

  • 818,042 Adverse Events
  • 127,641 Doctor Visits
  • 83,412 Hospitalizations
  • 92,017 Urgent Care
  • 26,199 Disabled
  • 10,179 Bell’s Palsy
  • 10,304 Myocarditis
  • 8,408 Heart Attacks
  • 2,631 Miscarriages
  • 17,128 Deaths

Yet, according to Fauci, the vaccine is 100% safe and effective!

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.
Articles by: Martin Armstrong

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]